The pharmaceutical industry resides on a terrain riddled with ethical landmines across research, product development, AI-enabled technologies, manufacturing, and commercialization over which pharma, biotech, and other life sciences companies must tread lightly.
Fujifilm Holdings America Corporation recognized it was no exception and decided to take a proactive
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
